Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $14.9M (159,701 shares) of Boston Scientific on Feb 2, 2026. Filing
- Last sale before this period: Jun 2, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Boston Scientific (BSX) | Chairman, President & CEO, Director | Nov 3, 2011 | Aug 5, 2026 |
| CVS Health (CVS) | Director | Nov 3, 2023 | May 15, 2026 |
| Baxter International (BAX) | Former Director | Oct 22, 2015 | May 4, 2023 |
Also a director at
CVS Health (CVS), Baxter International (BAX) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 3, 2026, Boston Scientific: bought 186,240 shares for $9.0M; 22,119 shares reported as discretionary (some held indirectly). 1 filing: 1
- May 28, 2026, Boston Scientific: 386,755 shares given away (some held indirectly). 1 filing: 1
- Feb 16, 2026, Boston Scientific: 16,265 shares vested; 7,865 shares withheld by the company for taxes. 1 filing: 1
- Feb 14, 2026, Boston Scientific: 16,524 shares vested; 7,990 shares withheld by the company for taxes. 1 filing: 1
- Feb 13, 2026, Boston Scientific: 264,380 shares awarded; 8,832 shares vested; 132,099 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.